BAUCHE; Cecile

Patent Applications and Registrations

Patent applications and USPTO patent grants for BAUCHE; Cecile.The latest application filed is for "anti-cd3 aptamers for use in cell targeting and labeling".

Company Profile

3.14.24

BAUCHE; Cecile - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-CD3 Aptamers for Use in Cell Targeting and Labeling App 20220251562 - MIODEK; Anna ; et al.	2022-08-11
Aptamer-Based CAR T-Cell Switch App 20210292760 - MIODEK; Anna ; et al.	2021-09-23
Lentiviral Vectors For Regulated Expression Of A Chimeric Antigen Receptor Molecule App 20210009653 - AGAUGUE; Sophie ; et al.	2021-01-14
Polymer-Encapsulated Viral Vectors for Genetic Therapy App 20200360297 - BAUCHE; Cecile ; et al.	2020-11-19
Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule Grant 10,752,668 - Agaugue , et al. A	2020-08-25
Viral Vector Constructs for Expression of Genetic Adjuvants Activating the CD40 and STING Pathways App 20200199620 - BAUCHE; Cecile ; et al.	2020-06-25
Lyophilized lentiviral vector particles, compositions and methods Grant 10,538,785 - Bauche , et al. Ja	2020-01-21
Viral Vector Constructs for Expression of Genetic Adjuvants Activating the STING Pathway App 20190328872 - BAUCHE; Cecile ; et al.	2019-10-31
Vectors for molecule delivery to CD11b expressing cells Grant 10,004,794 - LeClerc , et al. June 26, 2	2018-06-26
Lentiviral vectors for generating immune responses against human T Lymphotrophic Virus Type 1 Grant 9,987,351 - Revaud , et al. June 5, 2	2018-06-05
Use Of Non-subtype B Gag Proteins For Lentiviral Packaging App 20170362607 - TRAN; Thi-Lan ; et al.	2017-12-21
Use of non-subtype B gag proteins for lentiviral packaging Grant 9,752,160 - Tran , et al. September 5, 2	2017-09-05
Lentiviral Vectors For Regulated Expression Of A Chimeric Antigen Receptor Molecule App 20170166623 - AGAUGUE; Sophie ; et al.	2017-06-15
Lentiviral vectors containing an MHC class I, MHC class II, or B2 microglobulin upstream promoter sequence Grant 9,657,311 - Bauche , et al. May 23, 2	2017-05-23
Lyophilized Lentiviral Vector Particles, Compositions and Methods App 20170037430 - Bauche; Cecile ; et al.	2017-02-09
VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS App 20160375119 - LeClerc; Claude ; et al.	2016-12-29
Lentiviral Vectors For Generating Immune Responses Against Human T Lymphotrophic Virus Type 1 App 20160331831 - Revaud; Deborah ; et al.	2016-11-17
Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens Grant 9,410,139 - Dadaglio , et al. August 9, 2	2016-08-09
Vectors for molecule delivery to CD11b expressing cells Grant 9,370,564 - LeClerc , et al. June 21, 2	2016-06-21
Glycoproteins For Pseudotyping Lentivectors App 20150182617 - Bauche; Cecile ; et al.	2015-07-02
Lentiviral vectors containing an MHC class I promoter Grant 8,951,535 - Bauche , et al. February 10, 2	2015-02-10
Lentiviral Vectors Containing An Mhc Class I, Mhc Class Ii, Or B2 Microglobulin Upstream Promoter Sequence App 20140356946 - BAUCHE; Cecile ; et al.	2014-12-04
Use Of Non-subtype B Gag Proteins For Lentiviral Packaging App 20140234908 - Tran; Thi-Lan ; et al.	2014-08-21
Lentiviral Vectors Containing An Mhc Class I Promoter App 20140120132 - BAUCHE; Cecile ; et al.	2014-05-01
VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS App 20120214206 - LeClerc; Claude ; et al.	2012-08-23
Modified Bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof Grant 7,906,123 - Leclerc , et al. March 15, 2	2011-03-15
Recombinant Adenylate Cyclase Toxin Of Bordetella Induces T Cell Responses Against Tumoral Antigens App 20100310594 - Dadaglio; Gilles ; et al.	2010-12-09
Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens App 20090117143 - Dadaglio; Gilles ; et al.	2009-05-07
Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigens App 20070026022 - Dadaglio; Gilles ; et al.	2007-02-01
Modified bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof App 20060159697 - Leclerc; Claude ; et al.	2006-07-20
Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigens App 20050271679 - Dadaglio, Gilles ; et al.	2005-12-08
Vectors for molecule delivery to CD11b expressing cells App 20050238637 - Leclerc, Claude ; et al.	2005-10-27
Vectors for molecule delivery to CD11b expressing cells App 20040001867 - Leclerc, Claude ; et al.	2004-01-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.